Chinese Researchers Develop Lipid-lowering Small Compound DC371739
LIU Hong and HUANG He from Shanghai Institute of Materia Medica of the Chinese Academy of Sciences, identified the novel target of hyperlipidemia, and developed a novel lipid-lowering small compound DC371739, which showed a promising lipid-lowering effect in vitro and in vivo, as well as good safety and tolerability both in healthy subjects and in patients with hyperlipidemia in the phase one trial.
Apr 25, 2022